- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03666286
Prospective Registry of Mobilization-, Routine- and Outcome Data of Intensive Care Patients (MOBDB)
November 21, 2023 updated by: Stefan Schaller, Technical University of Munich
Registry database of intensive care patients.
These data comprises of routine data including mobilization data and follow up assessments.
Study Overview
Status
Active, not recruiting
Detailed Description
Registry database of intensive care patients. These data comprises of routine data including mobilization data and follow up assessments.
The database is supposed to help quality improvement as well as
Study Type
Observational
Enrollment (Estimated)
10000
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Bavaria
-
Munich, Bavaria, Germany, 81675
- Klinikum rechts der Isar der TUM
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
N/A
Sampling Method
Probability Sample
Study Population
Intensive Care Unit Patients
Description
Inclusion Criteria:
- Intensive care unit stay > 24 hours
Exclusion Criteria:
-
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
Intensive Care Patients
Patients >24h on intensive care
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Physical Function at hospital discharge
Time Frame: At hospital discharge, on average within 1 month
|
Physical function at ICU discharge with either the mmFIM (minimal modified Functional Independence Measure) or the Barthel subdomains transfer, locomotion and climbing stairs
|
At hospital discharge, on average within 1 month
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Hospital Mortality
Time Frame: At hospital discharge, on average within 1 month
|
Hospital Mortality
|
At hospital discharge, on average within 1 month
|
Pre-ICU Function
Time Frame: 2 weeks before ICU admission
|
Pre-ICU Function assessed with the WHODAS 2.0 (World Health Organisation's Disability Assessment Schedule), EQ5D (European Quality of Life 5 Dimensions 5 Level) and work details
|
2 weeks before ICU admission
|
Global function of the patient
Time Frame: 180 and 360 days after ICU discharge
|
Global function of the patient assessed with the WHODAS 2.0 (World Health Organisation's Disability Assessment Schedule)
|
180 and 360 days after ICU discharge
|
Physical function of the patient
Time Frame: 180 and 360 days after ICU discharge
|
Physical function of the patient assessed with the IADL (The Lawton Instrumental Activities of Daily Living)
|
180 and 360 days after ICU discharge
|
Quality of Life of the patient
Time Frame: 180 and 360 days after ICU discharge
|
Quality of Life of the patient assessed with the EQ5D (European Quality of Life 5 Dimensions 5 Level)
|
180 and 360 days after ICU discharge
|
Cognitive Function
Time Frame: 180 and 360 days after ICU discharge
|
Cognitive Function assessed with the MoCA blind (Montreal Cognitive Assessment)
|
180 and 360 days after ICU discharge
|
Anxiety and Depression
Time Frame: 180 and 360 days after ICU discharge
|
Anxiety and Depression assessed with the IES-R (Impact of Event Scale - Revised) and HADS (Hospital Anxiety and Depression scale)
|
180 and 360 days after ICU discharge
|
Return to work
Time Frame: 180 and 360 days after ICU discharge
|
Return to work assessed with the WHODAS 2.0 (World Health Organisation's Disability Assessment Schedule)
|
180 and 360 days after ICU discharge
|
ICU Mortality
Time Frame: At ICU Discharge, on average within 2 weeks
|
ICU Mortality
|
At ICU Discharge, on average within 2 weeks
|
Physical function at ICU discharge
Time Frame: At ICU Discharge, on average within 2 weeks
|
Physical function at ICU discharge with either the mmFIM (minimal modified Functional Independence Measure) or the Barthel subdomains transfer, locomotion and climbing stairs
|
At ICU Discharge, on average within 2 weeks
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Disability-Free survival
Time Frame: 180 and 360 days after ICU discharge
|
Disability-Free survival
|
180 and 360 days after ICU discharge
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Stefan J Schaller, MD, Technical University of Munich
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 1, 2017
Primary Completion (Estimated)
December 31, 2030
Study Completion (Estimated)
December 31, 2030
Study Registration Dates
First Submitted
September 4, 2018
First Submitted That Met QC Criteria
September 7, 2018
First Posted (Actual)
September 11, 2018
Study Record Updates
Last Update Posted (Estimated)
November 22, 2023
Last Update Submitted That Met QC Criteria
November 21, 2023
Last Verified
November 1, 2023
More Information
Terms related to this study
Other Study ID Numbers
- MOBDB
- DRKS00011576 (Registry Identifier: German Clinical Trials Register)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
IPD Plan Description
Sharing of anonymous data might be possible on reasonable scientific request.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Rehabilitation
-
Westfälische Wilhelms-Universität MünsterNational Paralympic Committee Germany (NPCG)CompletedCardiac Rehabilitation | Feasibility Studies | Organization and Administration | Rehabilitation ExerciseGermany
-
Asan Medical CenterRecruitingPulmonary Rehabilitation | Cardiac RehabilitationKorea, Republic of
-
University Hospital, ToursCompletedPulmonary Rehabilitation | Respiratory RehabilitationFrance
-
Suleyman Demirel UniversityCompleted
-
Orton Orthopaedic HospitalCompleted
-
Richard Watson, PTCompletedMedial Patellar Femoral Ligament Reconstruction Rehabilitation | Anterior Cruciate Ligament Reconstruction RehabilitationUnited States
-
Cairo UniversityRecruiting
-
Bruyere Research InstituteBruyere Academic Medical OrganizationRecruiting
-
National Cheng Kung UniversityRecruiting
-
University College AbsalonUniversity of Southern Denmark; Arla Foods; Danish Council for Independent Research and other collaboratorsCompleted